Assessment of dementia and use of anti-dementia drugs in nursing homes;Utredning av demens og bruk av legemidler mot demens i sykehjem

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 9, 2005, Pages 1188-1190

  Engedal, Knut ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; RIVASTIGMINE; DOPAMINE RECEPTOR STIMULATING AGENT; MEMANTINE;

AGED; ALZHEIMER DISEASE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DEPRESSION; DISEASE SEVERITY; GERIATRIC CARE; HEALTH CARE PERSONNEL; HUMAN; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NURSE; NURSING HOME; OCCUPATIONAL THERAPIST; PHYSICIAN; QUESTIONNAIRE; RATING SCALE; SHORT SURVEY; SYMPTOMATOLOGY; TEAMWORK; THYROID FUNCTION TEST; NORWAY; PATIENT CARE PLANNING; PSYCHOLOGICAL RATING SCALE; REVIEW;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DEMENTIA; DOPAMINE AGENTS; HUMANS; MEMANTINE; NORWAY; NURSING HOMES; PATIENT CARE PLANNING; PSYCHIATRIC STATUS RATING SCALES;

EID: 18744380383     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Ottt A, Breteler MMB, van Harskamp F et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995; 310: 970-3.
2. Engedal K, Haugen PK. The prevalence of dementia in a sample elderly Norwegians. Int J Geriatr Psychiatry 1993; 8: 565-70.
3. Nygaard HA, Ruths S. Missing the diagnosis: senile dementia in patients admitted to nursing homes. Scand J Prim Health Care 2003; 21: 148-52.
4. Bekkelund S, Kujala I, Rosenvinge B. Unrecognized dementia in elderly patients admitted to hospital with psychiatric symptoms. J Geriatr Psychiatr Neurol 2001; 14: 7-10.
5. Syse A. Pasientrettighetsloven. Oslo: Gyldendal, 2004
6. Medicines and Healthcare Products Regulatory Agency, www.mca.gov.uk/ ourwork/monitorsafequalmed/safetymessages/risperidoneclinicaltrialdata_final. pdf (5.1.2005).
7. Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry 1988; 152: 209-13.
8. Anamneseskjema for pararende. www.legeforeningen.no/assets/IQ%20CODE.doc (17.1.2005).
9. Nygård HA, Bråne G. Ny skala til gradering av senil demens. Tidsskr Nor Lægeforen 1987; 107: 546-7.
10. Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-72.
11. Malouf R, Aerosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003; CD004326.
12. Qizilbash N. Treatment of Alzheimer's disease. I: Qizilbash N, Schneider L, Chui H et al. Evidence-based dementia practice. Oxford: Blackwell, 2002: 467-588.
13. Areosa Sastre A, Sheriff F. Memantine for dementia (Cohrane review). I: The Cochrane Library, Issue 1, 2003. Oxford: Update Software.
14. Winblad B, Engedal K, Soininen H et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57: 489-95.
15. Black S, Roman GC, Geldmacher DS et al. Efficacy and tolerability of donepezil in vascular dementia. Positive results of a 24 week, multicenter, international, randomized placebo-controlled clinical trial. Stroke 2003; 34: 2323-32
16. McKeith I, Del Ser T, Spano P et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-6.
17. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004; 363: 2105-15.
18. Feldman H, Gauthier S, Hecker J et al. A 24 week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 2001; 57: 613-20.